Kotak Mahindra Bank Rs 685



Similar documents
Gujarat State Petronet Ltd. INR 135

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI.

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16%

GAIL (India) Ltd. INR 346

Minda Industries Ltd. INR 886

Khambatta Securities Ltd.

Quant Picks United Breweries

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Cipla Ltd. Rs India Equity Institutional Research Pharma. One off revenues from Nexium supply drives earnings HOLD. Target Price (Rs): 765

Granules India Ltd. INR 113

Axis Bank. Strong core performance. Source: Company Data; PL Research

Britannia Industries

Research Analysts. June 30, Lupin LUPIN Buy in the range of

State Bank of India. Source: Company Data; PL Research

Flexituff International Ltd. (FIL)

GlaxoSmithKline Consumer Healthcare

Research Analysts. September 30, 2015

Maruti Suzuki. Source: Company Data; PL Research

Federal Bank (FEDBAN) 50

Strong operational performance

HCC BUY. Infrastructure January 29, 2016

Research Analysts. Granules GRANUL Buy in the range of EID Parry EIDPAR Buy in the range of

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, Target Price Rs788

Cipla Ltd. INR 542. India Equity Institutional Research Pharma. Muted quarter; outlook remains robust. Target Price (INR): 646. Potential Upside : 19%

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

Gladiator Stocks: Phillips Carbon Black (PHICAR) Time Frame: Six months

The Ramco Cements. Source: Company Data; PL Research

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

How To Grow In Kotak Bank

Company Overview. Financial Performance

Pidilite Industries. Source: Company Data; PL Research

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Simplex Infrastructures

City Union Bank (CITUNI) 87

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Techno Electric & Engineering Limited

Tree House Education & Accessories

Results impacted by subdued demand

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

Navin Fluorine International

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

Larsen & Toubro. Source: Company Data; PL Research

Butterfly Gandhimathi (GANAP) 188

Shriram Transport Finance

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

Mangalam Cement Weak volumes marred performance

Higher other income drive the quarter

HCL Technologies BUY. Performance Highlights CMP. `857 Target Price `1,132. 1QFY2016 Result Update IT. 3-year price chart

Merger of ING Vysya Bank with Kotak Mahindra Bank

India Equity Research Telecommunications September 2, 2015 Management Meet Update

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

SKS Microfinance SELL. Need of the hour create floating provisions. Results Review INDIA TP: INR % SKSM IN

Second Quarter 2015 Trading Update. 28 September 2015

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

SREI Infrastructure Ltd.

Emirates NBD (ENBD) Strong Buy. Target Price AED10.0. Global Research Investment Update Equity UAE Banking Sector 31 January, 2016

Axis Bank BUY. More misses than hits. Results Review INDIA TP: INR % AXSB IN

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Jubilant Life Sciences

Merger of ING Vysya Bank with Kotak Mahindra Bank

KOTAK MAHINDRA BANK LIMITED

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP Target Price JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

Outlook and valuation

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

HDFC Bank BUY. Strong, solid, steady. Results Review INDIA TP: INR 1, % HDFCB IN

Va Tech Wabag. Source: Company Data; PL Research

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

BUY. ECLERX SERVICES LIMITED (CONSOLIDATED) Result Update: Q1 FY16. CMP Target Price SEPTEMBER 2 nd, 2015 SYNOPSIS ISIN: INE738I01010

SKS Microfinance SELL. Need of the hour Create floating provisions. Results Review INDIA TP: INR % SKSM IN

Bright Smart (1428 HK)

Union Bank of India SELL. Impairment ratio high maintain SELL. Results Review INDIA TP: INR % UNBK IN

CMP: JUNE 2016 SWARAJ ENGINES LTD

RamKrishna Forgings Ltd.

Bank of Baroda SELL. Leaving legacy issues behind. Results Review INDIA TP: INR % BOB IN

Wipro BUY. Performance Highlights CMP. `573 Target Price `719. 2QFY2016 Result Update IT. Investment Period 12 Months. 3-year price chart

Bharti Infratel (BHAINF) 370

Just Dial Ltd Bloomberg Code: JUST IN

BUY. Lower realization impacts earnings CAIRN INDIA. Target Price: Rs 155. Analyst call highlights

MOSt Market Outlook 1st, July 2016

BUY GUJARAT STATE PETRONET. Operationally in line; other income surprises. Target Price: Rs 160. Valuations comfortable. Visible triggers ahead

HOLD ASTRAL POLYTECHNIK. Q3 muted; recovery ahead. Target Price: Rs 377. Key highlights. Key drivers

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Transcription:

India Equity Institutional Research BANKS RESULT UPDATE Kotak Mahindra Bank Rs 685 Smooth merger; benefits to accrue HOLD KMB s consolidated PAT for Q4FY15 stood at INR 9.5 that primarily on the back of decent loan traction, (8% q/q), margins expansion (10 bp q/q) and healthy performance of subsidiaries. However, fee income performance remained tepid and operating expenses and credit costs stood higher. While the ING Vysya Bank merger is progressing smoothly, the unification should be complete by FY16-end. KMB has already engaged in retail product distribution through the ING branches. The synergy benefits in terms of cost savings and income should soon accrue. Persistent performance Steady loans, CASA improves, margins expand: NII grew 61.6% Y-o-Y & 5.0% Q-o-Q to INR 16.8 bn aided by 7.8% Q-o-Q loan book growth while margins surged 10 bps Q-o-Q. Low cost CASA mobilization during the quarter boosted margins expansion. Margins are expected to settle between 4.1-4.3% going forward. Non-interest income grew robustly by 32.0% Y-o-Y driven by core fee income at INR 4.6 bn and sizeable ARD buyout income of INR 650 mn. Operating expenses increased 61.9% Y-o-Y, but remained under control on Q-o-Q basis; the integration costs stood at INR 120 mn during Q2FY16. Moreover, the bank also incurred additional costs to the tune of INR 300 mn with respect to additional interest on savings account of eivbl to get it to 6%. While provisions on Y-o-Y basis stood staggering, sequentially they were down 42.2% boosting profit growth for the quarter. Consequently, standalone PAT increased 28.1% Y-o-Y to Rs 5.7 bn v/s INR 4.4 bn (Q2FY15). Most of the businesses reported decent growth with broking, investments and life insurance businesses stood strong during the quarter gone by. We expect the bank to deliver 21.3% CAGR in net earnings over FY16-FY18E driven by strong loan growth, steady NIMs and improving cost to income ratio. Target Price (Rs): 720 Potential upwnside:5% Market Data Shares outs (Mn) 1831 EquityCap(INR Mn) 9156 Mkt Cap (INR Mn) 1260899 52 Wk H/L (Mn) 744/532 Volume Avg(3m K) 1320.56 Face Value (INR) 5 Bloomberg Code KMB IN Market Info: SENSEX 26559 NIFTY 8051 Price Performance Tepid business growth: Loan book reported 8% q/q growth primarily driven by sturdy growth in corporate banking, business banking and home loans/lap business segments. Retail loan traction stood strong with most of the retails segments recording healthy growth. KMB management expects to clock robust 20% loan growth for current fiscal. Deposits, on the other hand, grew 5.5% q/q with traction emerging from CASA deposits. While the CA deposits grew 17% q/q, SA augmentation remained sedate with 7% q/q growth. The CASA ratio stood at 36% for the quarter. Asset quality slips: Asset quality slipped Y-o-Y with Gross NPA at 2.4% and net NPA at 1.1% during the quarter. The restructured loans (standard) stood at INR 4bn (0.4%) of which INR 2.6 bn emerged from e1vbl portfolio. Steady-state subsidiary performances: Healthy subsidiary profits have boosted the consolidated profits for KMB especially during the times of merger. Securities, Investment, Life Insurance and MF businesses have put up strong operating metrics and profitability. Moreover, going forward banking upon the synergy benefits, KMB should be in a position to boost its earnings further. Valuation & Recommendation: Barring Y-o-Y slip on asset quality, Q2FY16 earnings stood strong for the bank; both standalone and consolidated levels during the quarter. We believe 20%+ loan growth outlook, margin preservation, lower credit costs, cash recoveries from marked down acquired stressed assets pull and operating leverage on newly open branches will support earnings growth over FY15-FY17. We believe strong core capitalization, superior margins & asset quality, capital linked businesses revenues, improving liability franchise and synergy benefits accruing from ING Vysya Bank merger from Q1FY17 aiding banking business and strengthening market positioning are key value drivers for Kotak. Considering the synergy transition and incorporating the same into our financial estimates, we maintain HOLD rating with a target price of Rs 720 as per SOTP valuations (valuing the core bank at 3.4x FY17E P/ABV). Key Financials Standalone Particulars FY13 FY14 FY15 FY16E FY17E Net Interest Income 32,057 37,200 61,953 79,960 101,235 Pre-provision profits 21,566 25,771 42,315 56,483 72,815 Net Profit 13,607 15,025 24,834 33,567 42,881 EPS ( ) 18.3 19.8 24.1 24.5 23.5 BVPS ( ) 126.8 159.5 238.8 138.9 161.0 ABVPS ( ) 124.1 154.7 232.9 135.1 156.7 P/E (x) 37.4 34.6 28.4 27.9 29.2 P/ABV (x) 5.5 4.4 2.9 5.1 4.4 Shareholding pattern (%) Particulars Sep15 Jun15 Mar15 Promoters 33.77 33.86 40.02 FIIs 34.67 35.32 36.85 DIIs 4.22 3.69 1.86 Others 27.34 27.13 21.27 Total 100 100 100 Source: BSE Shweta Mane-Daptardar shweta.mane@krchoksey.com 91-22-6696 5555 ext. 526 www.krchoksey.com 91-22-6696 5203 91-22-6691 9574 KRChoksey Research is also available on Bloomberg KRCS<GO>, ThomsonReuters, Factset and Capital IQ November 02, 2015

Q2FY16: Result Analysis Income Statement Standalone (INR in mn) Q2FY16 Q1FY16 Q2FY15 Q-o-Q Y-o-Y Income Statement - Standalone Interest income 40,057 39,914 23,525 0.4% 70.3% Interest expense 23,269 23,932 13,136-2.8% 77.1% Net interest income 16,787 15,982 10,389 5.0% 61.6% Non interest income 6,157 5,924 4,665 3.9% 32.0% Total Net Income 22,945 21,906 15,054 4.7% 52.4% -- Employee costs 6,230 9,288 3,545-32.9% 75.7% -- Other operating expenses 6,267 6,649 4,172-5.7% 50.2% Operating expenses 12,497 15,937 7,717-21.6% 61.9% Pre-provision profits 10,448 5,970 7,336 75.0% 42.4% Provisions 1764 3053 537-42.2% 228.8% Profit before tax 8,684 2,917 6,800 197.7% 27.7% Tax expense 2,989 1,019 2,355 193.3% 26.9% Net profit 5,695 1,898 4,445 200.1% 28.1% Key balance sheet items & Asset quality - Standalone (INR in mn) Q4FY15 Q3FY15 Q4FY14 Y-o-Y Q-o-Q Networth 226,082 218,902 132,048 3.3% 71.2% Deposits 1,232,111 1,168,120 681,026 5.5% 80.9% Borrowings 218,727 214,353 105,540 2.0% 107.2% Advances 1,116,618 1,036,144 609,477 7.8% 83.2% GNPA ratio 2.4% 2.3% 1.9% 0.0 0.5 NNPA ratio 1.1% 1.0% 1.0% 0.0 0.1 Provision coverage ratio 56.0% 55.5% 47.5% 0.5 8.5 CASA ratio 36.0% 34.3% 31.1% 1.7 4.9 Reported NIM 4.3% 4.2% 5.0% 0.1-0.7 CAR 15.5% 16.4% 17.6% -0.9-2.1 Business segment wise profitability and consolidated PAT (INR in mn) Q1FY16 Q2FY15 Q2FY16 Kotak Mahindra Bank 1900 4450 5700 Kotak Life Insurance 660 520 480 Kotak AMC & TC 200-1 230 Kotak Securities 670 660 780 Kotak Mahindra Capital 30-70 70 Kotak Mahindra Prime 1190 1250 1270 Kotak Mahindra Investments 300 250 360 International Subsidiaries 250 130 320 Kotak Investment Advisors - 40 - Total 5200 7220 9190 MI, Equity Affiliates, Others -30-40 -230 Consolidated PAT 5170 7180 9420 2 KRChoksey - Institutional Research

Financials Income Statement INR in mn FY13 FY14 FY15E FY16E FY17E Interest income 80,425 87,671 155,236 186,972 226,199 Interest expenses 48,368 50,471 93,283 107,012 124,972 Net Interest Income 32,057 37,200 61,953 79,960 101,227 Non interest income 11,607 13,997 29,060 35,067 42,166 Operating income 43,663 51,198 91,012 115,027 143,393 Operating expenses 22,097 25,426 48,698 58,544 70,586 -Employee cost 10,751 11,722 24,230 29,106 34,904 Pre-provision profits 21,566 25,771 42,315 56,483 72,807 Provisions 1,846 3,047 4,769 5,855 8,138 Profit before tax 19,721 22,724 37,546 50,628 64,669 Tax expense 6,113 7,699 12,711 17,062 21,793 Net profit 13,607 15,025 24,834 33,567 42,876 Interest income 80,425 87,671 155,236 186,972 226,199 Interest expenses 48,368 50,471 93,283 107,012 124,972 Net Interest Income 32,057 37,200 61,953 79,960 101,227 Balance Sheet INR in mn Equity share capital 3,733 3,852 4,556 9,129 9,129 Reserve and Surplus 90,912 118,985 213,074 244,513 284,841 Net worth 94,645 122,836 217,631 253,642 293,969 Deposits 510,288 590,723 1,228,725 1,514,611 1,893,264 Borrowings 204,106 128,956 204,031 257,566 301,801 Other liabilities and provisions 27,898 33,338 93,143 96,498 100,440 Total 836,936 875,853 1,743,530 2,122,318 2,589,474 Cash in hand and Bal. with RBI 36,892 59,799 109,310 124,052 149,264 Investments 288,734 254,845 499,369 585,397 694,823 Advances 484,690 530,276 1,080,348 1,350,115 1,674,400 Fixed assets 4,644 11,069 17,228 19,811 22,615 Other assets 21,977 19,863 37,274 42,942 48,372 Total 836,937 875,853 1,743,530 2,122,318 2,589,474 DuPont Analysis (As % Average assets) NII 4.3% 4.3% 3.8% 4.1% 4.3% Fee Income 1.2% 1.3% 1.4% 1.4% 1.4% Treasury Income 0.2% 0.2% 0.2% 0.2% 0.2% Operating Cost 3.0% 3.0% 3.0% 3.0% 3.0% Provisions 0.2% 0.4% 0.3% 0.3% 0.3% Tax 0.8% 0.9% 0.8% 0.9% 0.9% RoAA 1.8% 1.8% 1.5% 1.7% 1.8% ROAE 15.6% 13.8% 12.1% 14.2% 15.7% Spread Analysis Avg Yield On Advances 14.1% 13.3% 12.0% 11.8% 11.7% Avg Yield On Investments 7.8% 7.7% 8.0% 8.0% 7.8% Avg Yield On Int Earning Assets 10.7% 10.1% 10.0% 10.0% 9.9% Avg Cost Of Deposits 7.5% 6.9% 6.9% 6.5% 6.2% Avg Cost of Funds 7.6% 7.0% 7.0% 6.6% 6.3% Spread 3.5% 3.6% 3.0% 3.4% 3.6% NIM 4.5% 4.5% 4.5% 4.0% 4.3% 3 KRChoksey - Institutional Research

Business Profile Advances 484,690 530,276 1,080,348 1,350,115 1,674,400 Credit Deposits ratio 95.0% 89.8% 87.9% 89.1% 88.4% Deposits 510,288 590,723 1,228,725 1,514,611 1,893,264 CASA Deposits 283,534 325,865 425,545 542,764 678,455 CASA Ratio 29.2% 31.9% 34.6% 35.8% 35.8% Asset Quality Gross NPA 7,688 13,224 16,221 20,944 24,418 Net NPA 3,376 7,374 8,435 10,891 12,209 Gross NPA as % of Advances 1.5% 2.0% 1.5% 1.5% 1.4% Net NPA as % of Advances 0.6% 1.1% 0.8% 0.8% 0.7% Credit Costs 0.5% 0.3% 0.4% 0.6% 0.7% Growth ratios Net interest income 27.6% 16.0% 46.7% 29.1% 26.6% Pre-provision Profits 30.0% 43.8% 41.2% 88.4% 28.9% Net Profits 25.4% 10.4% 24.2% 33.1% 35.2% Advances 18.3% 67.6% 63.3% 104.1% 24.0% Deposits 25.3% 69.8% 64.1% 102.3% 25.0% Total Assets 23.0% 69.0% 64.5% 100.2% 22.0% Per share Data and valuation (INR) EPS 18.3 19.8 24.1 24.5 23.5 DPS 0.7 0.8 1.1 1.3 1.2 BVPS 126.8 159.5 238.8 138.9 161.0 ABVPS 124.1 154.7 232.9 135.1 156.7 P/E 37.4 34.6 28.4 27.9 29.2 P/ABV 5.5 4.4 2.9 5.1 4.4 Dividend Yield 0.1% 0.1% 0.2% 0.2% 0.2% 4 KRChoksey - Institutional Research

Kotak Mahindra Bank Date CMP Target Recommendation 03-Nov-15 685 720 HOLD 13-Apr-15 1,422 1,400 REDUCE 21-Jan-15 1,389 1,400 HOLD 7-Jan-15 1,251 1,260 HOLD 28-Oct-14 1088 1111 HOLD 8-Oct-14 1006 1050 HOLD 16-Jul-14 884 1000 ACCUMULATE 9-Jul-14 869 1000 BUY 2-May-14 803 835 HOLD 9-Apr-14 755 670 SELL Rating Legend Our Rating Upside Buy More than 15% Accumulate 5% - 15% Hold 0 5% Reduce -5% 0 Sell Less than -5% ANALYST CERTIFICATION: I, Shweta Mane-Daptardar (B.Com, MBA), research associate, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & Conditions and other disclosures: KRChoksey Shares and Securities Pvt. Ltd (hereinafter referred to as KRCSSPL) is a registered member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and MCX Stock Exchange Limited. KRCSSPL is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. We submit that no material disciplinary action has been taken on KRCSSPL and its associates by any Regulatory Authority impacting Equity Research Analysis activities. KRCSSPL generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analyst covers. The information and opinions in this report have been prepared by KRCSSPL and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of KRCSSPL. While we would endeavor to update the information herein on a reasonable basis, KRCSSPL is not under any obligation to update the information. Also, there may be regulatory, compliance or other reasons that may prevent KRCSSPL from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or KRCSSPL policies, in circumstances where KRCSSPL might be acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. KRCSSPL will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. KRCSSPL accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Our employees in sales and marketing team, dealers and other professionals may provide oral or written market commentary or trading strategies that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. KRCSSPL or its associates might have received any commission/compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of brokerage services or specific transaction or for products and services other than brokerage services. KRCSSPL encourages the practice of giving independent opinion in research report preparation by the analyst and thus strives to minimize the conflict in preparation of research report. KRCSSPL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither KRCSSPL nor Research Analysts have any material conflict of interest at the time of publication of this report. It is confirmed that Shweta Mane-Daptardar (B.Com, MBA) research associate of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Compensation of our Research Analysts is not based on any specific brokerage service transactions. KRCSSPL or its associates collectively or its research analyst do not hold any financial interest/beneficial ownership of more than 1% (at the end of the month immediately preceding the date of publication of the research report) in the company covered by Analyst, and has not been engaged in market making activity of the company covered by research analyst. Since associates of KRCSSPL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. It is confirmed that Shweta Mane-Daptardar (B.Com, MBA) research associate do not serve as an officer, director or employee of the companies mentioned in the report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject KRCSSPL and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Please send your feedback to research.insti@krchoksey.com Visit us at www.krchoksey.com Kisan Ratilal Choksey Shares and Securities Pvt. Ltd Registered Office: 1102, Stock Exchange Tower, Dalal Street, Fort, Mumbai 400 001. Phone: 91-22-6633 5000; Fax: 91-22-6633 8060. Corporate Office: ABHISHEK, 5th Floor, Link Road, Andheri (W), Mumbai 400 053. Phone: 91-22-6696 5555; Fax: 91-22-6691 9576. 5 KRChoksey - Institutional Research